BCL9 and neoplasm: We show that both in vivo and in vitro miR-1301 suppresses tumor migration invasion and angiogenesis by targeting multiple angiogenesis-inducing genes, including BCL9, β-catenin, and vascular endothelial growth factor-A (VEGF-A), thus highlighting a dual role for miR-1301 in tumor metastasis.